Dermatologist Perceptions of Teledermatology Implementation
& Future Use Post COVID-19 Linda Camaj Deda
University of Michigan Medical School, Ann ArborDepartment of Dermatology, University of Michigan, Ann Arbor
AAD Taskforce Collaborators
Rebecca Goldberg, BSTrilokraj Tejasvi, MBBS, MD
Jules B. Lipoff, MDJonathan Kennedy, BS
Siobhan Arey, MPH, MS, PA-CZachary Hopkins, MD
Ramsay Farah, MDAaron M. Secrest, MD, PhD
George Han, MDJason G. Mathis, MD
Rosie Balk, MAMartha Wojtowycz, PhD
Changes in Teledermatology in Setting of COVID-19 Pandemic
Regulatory Changes from the US Centers for Medicare & Medicaid Services
Parity in reimbursement between in-person and video visits
Removing eligibility and geographic restrictions
Methods
TopicsModes Used Situational Appropriateness Reimbursement Perceived NeedBarriers Anticipated Future Use
In May-June 2020, AAD Task Force Subgroup surveyed AAD members regarding effects of COVID-19 on teledermatology
12,070 practicing US dermatologist members of AAD
5,000 randomly selected
4,356 received the survey
591 completed surveys (13.6% response rate)
➥ 644 non-functioning email addresses
Results
14% 97%Prior COVID-19 During COVID-19
Anticipated personal continued use
70%
Teledermatology Utilization
Anticipated Future of Teledermatology
58%Believed teledermatology
will continue post-pandemic
ResultsAppropriate Utilization
LO, live office visitLV, live video visitSDP, stored digital photography
96%
3%
ResultsBarriers
Technology Issues (39%)
Low Reimbursement (70%)
Malpractice/Liability Concerns (27%)
Government Regulations (23%)
Conclusions➥ Teledermatology is likely here to stay.
➥ There are concerns highlighting the need for supportive reimbursement, regulations, and technological innovation (improved connectivity and functionality of video visit platforms).
➥ Refinement of workflow by patient and visit-type selection will likely improve how teledermatology is perceived by dermatologists.
We hope that this data can inform policy changes to address barriers to use.
Cited SourcesCoates SJ, Kvedar J, Granstein RD. Teledermatology: from historical perspective to emerging techniques of the modern era: part I: history, rationale, and current practice. J Am Acad Dermatol. 2015;72(4):563-574. doi:10.1016/j.jaad.2014.07.061PubMedGoogle ScholarCrossref
Harvey JB, Valenta S, Simpson K, Lyles M, McElligott J. Utilization of outpatient telehealth services in parity and nonparity states 2010-2015. Telemed J E Health. 2019;25(2):132-136. doi:10.1089/tmj.2017.0265PubMedGoogle ScholarCrossref
Lee I, Kovarik C, Tejasvi T, Pizarro M, Lipoff JB. Telehealth: helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation. J Am Acad Dermatol. 2020;82(5):1213-1214. doi:10.1016/j.jaad.2020.03.052PubMedGoogle ScholarCrossref
US Centers for Disease Control and Prevention. Using telehealth to expand access to essential health services during the COVID-19 pandemic. Updated June 10, 2020. Accessed July 18, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/telehealth.html
Perkins S, Cohen JM, Nelson CA, Bunick CG. Teledermatology in the era of COVID-19: experience of an academic department of dermatology. J Am Acad Dermatol. 2020;83(1):e43-e44. doi:10.1016/j.jaad.2020.04.048PubMedGoogle ScholarCrossref
Cited ImagesCenters for Medicare and Medicaid Services logo, 1 April 2014, CMS Branding Guidelines, Centers for Medicare and Medicaid Services. As a work of the U.S. federal government, the image is in the public domain.
The greater coat of arms of the United States of America. Ssolbergj, CC BY-SA 3.0 <https://creativecommons.org/licenses/by-sa/3.0>, via Wikimedia Commons
Stock Photos, Canva (2021)